Skip to main content
Erschienen in: Surgical Endoscopy 9/2015

01.09.2015

Concomitant cholecystectomy during laparoscopic sleeve gastrectomy

verfasst von: Asnat Raziel, Nasser Sakran, Amir Szold, David Goitein

Erschienen in: Surgical Endoscopy | Ausgabe 9/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

The prevalence of cholelithiasis in morbidly obese individuals is 19–45 %. Laparoscopic sleeve gastrectomy (LSG) has become one of the most performed procedures worldwide. The management of gallstones at the time of LSG is under debate. We herein report our experience with concomitant LSG and cholecystectomy.

Methods

Patients undergoing LSG, between 2006 and 2014 with symptomatic cholelithiasis (SC), underwent concomitant cholecystectomy (SGC), and were compared to those who had LSG alone. Gender, age, and BMI were noted. Preoperative ultrasonography was performed for all patients and gallstone presence was recorded. Operative time, intraoperative mishaps, perioperative complications, length of hospital stay (LOS), and the incidence of subsequent symptomatic gallbladder disease were collected as well.

Results

SC was present in 180 patients who underwent SGC. LSG was performed in 2,383, of whom 43 (2 %) had asymptomatic cholelithiasis (AC). SGC patients had a higher percentage of females and were older (79 % and 46 years vs. 62 % and 43 years, respectively). BMI, LOS, and complications were similar. Operative time was prolonged by 35 min in SGC. Two patients with SGC had bile leakage. Of patients with AC, 9.3 % required cholecystectomy during the first post-operative year after LSG due to evolution of symptoms, compared to only 2.7 % of those with normal preoperative gallbladders. Presenting symptoms and severity of the disease were worse in the first group.

Conclusions

For SC, LSC is safe and warranted. Prophylactic cholecystectomy when gallstones are absent is unnecessary. Management of AC at the time of LSG is still debatable.
Literatur
1.
Zurück zum Zitat Buchwald H, Oien DM (2009) Metabolic/bariatric surgery Worldwide 2008. Obes Surg 19:1605–1611CrossRefPubMed Buchwald H, Oien DM (2009) Metabolic/bariatric surgery Worldwide 2008. Obes Surg 19:1605–1611CrossRefPubMed
2.
Zurück zum Zitat Kohn GP, Galanko JA, Overby DW, Farrell TM (2009) Recent trends in bariatric surgery case volume in the United States. Surgery 146:375–380CrossRefPubMed Kohn GP, Galanko JA, Overby DW, Farrell TM (2009) Recent trends in bariatric surgery case volume in the United States. Surgery 146:375–380CrossRefPubMed
3.
Zurück zum Zitat Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, Lamonte MJ, Stroup AM, Hunt SC (2007) Long-term mortality after gastric bypass surgery. N Engl J Med 357:753–761CrossRefPubMed Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, Lamonte MJ, Stroup AM, Hunt SC (2007) Long-term mortality after gastric bypass surgery. N Engl J Med 357:753–761CrossRefPubMed
4.
Zurück zum Zitat Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122(248–256):e245 Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122(248–256):e245
5.
Zurück zum Zitat Dittrick GW, Thompson JS, Campos D, Bremers D, Sudan D (2005) Gallbladder pathology in morbid obesity. Obes Surg 15:238–242CrossRefPubMed Dittrick GW, Thompson JS, Campos D, Bremers D, Sudan D (2005) Gallbladder pathology in morbid obesity. Obes Surg 15:238–242CrossRefPubMed
6.
Zurück zum Zitat Shiffman ML, Sugerman HJ, Kellum JH, Brewer WH, Moore EW (1993) Gallstones in patients with morbid obesity. Relationship to body weight, weight loss and gallbladder bile cholesterol solubility. Int J Obes Relat Metab Disord 17:153–158PubMed Shiffman ML, Sugerman HJ, Kellum JH, Brewer WH, Moore EW (1993) Gallstones in patients with morbid obesity. Relationship to body weight, weight loss and gallbladder bile cholesterol solubility. Int J Obes Relat Metab Disord 17:153–158PubMed
7.
Zurück zum Zitat Torgerson JS, Lindroos AK, Naslund I, Peltonen M (2003) Gallstones, gallbladder disease, and pancreatitis: cross-sectional and 2-year data from the Swedish Obese Subjects (SOS) and SOS reference studies. Am J Gastroenterol 98:1032–1041PubMed Torgerson JS, Lindroos AK, Naslund I, Peltonen M (2003) Gallstones, gallbladder disease, and pancreatitis: cross-sectional and 2-year data from the Swedish Obese Subjects (SOS) and SOS reference studies. Am J Gastroenterol 98:1032–1041PubMed
8.
Zurück zum Zitat Shiffman ML, Sugerman HJ, Kellum JM, Brewer WH, Moore EW (1991) Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity. Am J Gastroenterol 86:1000–1005PubMed Shiffman ML, Sugerman HJ, Kellum JM, Brewer WH, Moore EW (1991) Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity. Am J Gastroenterol 86:1000–1005PubMed
9.
Zurück zum Zitat Jonas E, Marsk R, Rasmussen F, Freedman J (2010) Incidence of postoperative gallstone disease after antiobesity surgery: population-based study from Sweden. Surg Obes Relat Dis 6:54–58CrossRefPubMed Jonas E, Marsk R, Rasmussen F, Freedman J (2010) Incidence of postoperative gallstone disease after antiobesity surgery: population-based study from Sweden. Surg Obes Relat Dis 6:54–58CrossRefPubMed
10.
Zurück zum Zitat Liem RK, Niloff PH (2004) Prophylactic cholecystectomy with open gastric bypass operation. Obes Surg 14:763–765CrossRefPubMed Liem RK, Niloff PH (2004) Prophylactic cholecystectomy with open gastric bypass operation. Obes Surg 14:763–765CrossRefPubMed
11.
Zurück zum Zitat Fuller W, Rasmussen JJ, Ghosh J, Ali MR (2007) Is routine cholecystectomy indicated for asymptomatic cholelithiasis in patients undergoing gastric bypass? Obes Surg 17:747–751CrossRefPubMed Fuller W, Rasmussen JJ, Ghosh J, Ali MR (2007) Is routine cholecystectomy indicated for asymptomatic cholelithiasis in patients undergoing gastric bypass? Obes Surg 17:747–751CrossRefPubMed
12.
Zurück zum Zitat Portenier DD, Grant JP, Blackwood HS, Pryor A, McMahon RL, DeMaria E (2007) Expectant management of the asymptomatic gallbladder at Roux-en-Y gastric bypass. Surg Obes Relat Dis 3:476–479CrossRefPubMed Portenier DD, Grant JP, Blackwood HS, Pryor A, McMahon RL, DeMaria E (2007) Expectant management of the asymptomatic gallbladder at Roux-en-Y gastric bypass. Surg Obes Relat Dis 3:476–479CrossRefPubMed
13.
Zurück zum Zitat Swartz DE, Felix EL (2005) Elective cholecystectomy after Roux-en-Y gastric bypass: why should asymptomatic gallstones be treated differently in morbidly obese patients? Surg Obes Relat Dis 1:555–560CrossRefPubMed Swartz DE, Felix EL (2005) Elective cholecystectomy after Roux-en-Y gastric bypass: why should asymptomatic gallstones be treated differently in morbidly obese patients? Surg Obes Relat Dis 1:555–560CrossRefPubMed
14.
Zurück zum Zitat Fobi M, Lee H, Igwe D, Felahy B, James E, Stanczyk M, Fobi N (2002) Prophylactic cholecystectomy with gastric bypass operation: incidence of gallbladder disease. Obes Surg 12:350–353CrossRefPubMed Fobi M, Lee H, Igwe D, Felahy B, James E, Stanczyk M, Fobi N (2002) Prophylactic cholecystectomy with gastric bypass operation: incidence of gallbladder disease. Obes Surg 12:350–353CrossRefPubMed
15.
Zurück zum Zitat Villegas L, Schneider B, Provost D, Chang C, Scott D, Sims T, Hill L, Hynan L, Jones D (2004) Is routine cholecystectomy required during laparoscopic gastric bypass? Obes Surg 14:206–211CrossRefPubMed Villegas L, Schneider B, Provost D, Chang C, Scott D, Sims T, Hill L, Hynan L, Jones D (2004) Is routine cholecystectomy required during laparoscopic gastric bypass? Obes Surg 14:206–211CrossRefPubMed
16.
Zurück zum Zitat Lopes TL, Wilcox CM (2010) Endoscopic retrograde cholangiopancreatography in patients with Roux-en-Y anatomy. Gastroenterol Clin North Am 39:99–107CrossRefPubMed Lopes TL, Wilcox CM (2010) Endoscopic retrograde cholangiopancreatography in patients with Roux-en-Y anatomy. Gastroenterol Clin North Am 39:99–107CrossRefPubMed
17.
Zurück zum Zitat Richardson JF, Lee JG, Smith BR, Nguyen B, Pham KP, Nguyen NT (2012) Laparoscopic transgastric endoscopy after Roux-en-Y gastric bypass: case series and review of the literature. Am Surg 78:1182–1186PubMed Richardson JF, Lee JG, Smith BR, Nguyen B, Pham KP, Nguyen NT (2012) Laparoscopic transgastric endoscopy after Roux-en-Y gastric bypass: case series and review of the literature. Am Surg 78:1182–1186PubMed
18.
Zurück zum Zitat Vilallonga R, Pimentel R, Rosenthal RJ (2013) Hybrid endolaparoscopic management of biliary tract pathology in bariatric patients after gastric bypass: case report and review of a single-institution experience. Surg Laparosc Endosc Percutan Tech 23:e188–e190CrossRefPubMed Vilallonga R, Pimentel R, Rosenthal RJ (2013) Hybrid endolaparoscopic management of biliary tract pathology in bariatric patients after gastric bypass: case report and review of a single-institution experience. Surg Laparosc Endosc Percutan Tech 23:e188–e190CrossRefPubMed
19.
Zurück zum Zitat Ceppa FA, Gagne DJ, Papasavas PK, Caushaj PF (2007) Laparoscopic transgastric endoscopy after Roux-en-Y gastric bypass. Surg Obes Relat Dis 3:21–24CrossRefPubMed Ceppa FA, Gagne DJ, Papasavas PK, Caushaj PF (2007) Laparoscopic transgastric endoscopy after Roux-en-Y gastric bypass. Surg Obes Relat Dis 3:21–24CrossRefPubMed
20.
Zurück zum Zitat Buchwald H, Oien DM (2013) Metabolic/bariatric surgery worldwide 2011. Obes Surg 23:427–436CrossRefPubMed Buchwald H, Oien DM (2013) Metabolic/bariatric surgery worldwide 2011. Obes Surg 23:427–436CrossRefPubMed
21.
Zurück zum Zitat Nguyen NT, Nguyen B, Gebhart A, Hohmann S (2013) Changes in the makeup of bariatric surgery: a national increase in use of laparoscopic sleeve gastrectomy. J Am Coll Surg 216:252–257CrossRefPubMed Nguyen NT, Nguyen B, Gebhart A, Hohmann S (2013) Changes in the makeup of bariatric surgery: a national increase in use of laparoscopic sleeve gastrectomy. J Am Coll Surg 216:252–257CrossRefPubMed
22.
Zurück zum Zitat Goitein D, Zendel A, Westrich G, Zippel D, Papa M, Rubin M (2013) Postoperative swallow study as a predictor of intermediate weight loss after sleeve gastrectomy. Obes Surg 23:222–225CrossRefPubMed Goitein D, Zendel A, Westrich G, Zippel D, Papa M, Rubin M (2013) Postoperative swallow study as a predictor of intermediate weight loss after sleeve gastrectomy. Obes Surg 23:222–225CrossRefPubMed
23.
Zurück zum Zitat Mason EE, Renquist KE (2002) Gallbladder management in obesity surgery. Obes Surg 12:222–229CrossRefPubMed Mason EE, Renquist KE (2002) Gallbladder management in obesity surgery. Obes Surg 12:222–229CrossRefPubMed
24.
Zurück zum Zitat Li VK, Pulido N, Martinez-Suartez P, Fajnwaks P, Jin HY, Szomstein S, Rosenthal RJ (2009) Symptomatic gallstones after sleeve gastrectomy. Surg Endosc 23:2488–2492CrossRefPubMed Li VK, Pulido N, Martinez-Suartez P, Fajnwaks P, Jin HY, Szomstein S, Rosenthal RJ (2009) Symptomatic gallstones after sleeve gastrectomy. Surg Endosc 23:2488–2492CrossRefPubMed
25.
Zurück zum Zitat Nougou A, Suter M (2008) Almost routine prophylactic cholecystectomy during laparoscopic gastric bypass is safe. Obes Surg 18:535–539CrossRefPubMed Nougou A, Suter M (2008) Almost routine prophylactic cholecystectomy during laparoscopic gastric bypass is safe. Obes Surg 18:535–539CrossRefPubMed
26.
Zurück zum Zitat Li VK, Pulido N, Fajnwaks P, Szomstein S, Rosenthal R, Martinez-Duartez P (2009) Predictors of gallstone formation after bariatric surgery: a multivariate analysis of risk factors comparing gastric bypass, gastric banding, and sleeve gastrectomy. Surg Endosc 23:1640–1644CrossRefPubMed Li VK, Pulido N, Fajnwaks P, Szomstein S, Rosenthal R, Martinez-Duartez P (2009) Predictors of gallstone formation after bariatric surgery: a multivariate analysis of risk factors comparing gastric bypass, gastric banding, and sleeve gastrectomy. Surg Endosc 23:1640–1644CrossRefPubMed
27.
Zurück zum Zitat Moon RC, Teixeira AF, Ducoin C, Varnadore S, Jawad MA (2013) Comparison of cholecystectomy cases after Roux-en-Y gastric bypass, sleeve gastrectomy, and gastric banding. Surg Obes Relat Dis 10:64–68CrossRefPubMed Moon RC, Teixeira AF, Ducoin C, Varnadore S, Jawad MA (2013) Comparison of cholecystectomy cases after Roux-en-Y gastric bypass, sleeve gastrectomy, and gastric banding. Surg Obes Relat Dis 10:64–68CrossRefPubMed
28.
Zurück zum Zitat Tucker ON, Fajnwaks P, Szomstein S, Rosenthal RJ (2008) Is concomitant cholecystectomy necessary in obese patients undergoing laparoscopic gastric bypass surgery? Surg Endosc 22:2450–2454CrossRefPubMed Tucker ON, Fajnwaks P, Szomstein S, Rosenthal RJ (2008) Is concomitant cholecystectomy necessary in obese patients undergoing laparoscopic gastric bypass surgery? Surg Endosc 22:2450–2454CrossRefPubMed
29.
Zurück zum Zitat Tsirline VB, Keilani ZM, El Djouzi S, Phillips RC, Kuwada TS, Gersin K, Simms C, Stefanidis D (2014) How frequently and when do patients undergo cholecystectomy after bariatric surgery? Surg Obes Relat Dis 10:313–321CrossRefPubMed Tsirline VB, Keilani ZM, El Djouzi S, Phillips RC, Kuwada TS, Gersin K, Simms C, Stefanidis D (2014) How frequently and when do patients undergo cholecystectomy after bariatric surgery? Surg Obes Relat Dis 10:313–321CrossRefPubMed
30.
Zurück zum Zitat Tarantino I, Warschkow R, Steffen T, Bisang P, Schultes B, Thurnheer M (2011) Is routine cholecystectomy justified in severely obese patients undergoing a laparoscopic Roux-en-Y gastric bypass procedure? A comparative cohort study. Obes Surg 21:1870–1878CrossRefPubMed Tarantino I, Warschkow R, Steffen T, Bisang P, Schultes B, Thurnheer M (2011) Is routine cholecystectomy justified in severely obese patients undergoing a laparoscopic Roux-en-Y gastric bypass procedure? A comparative cohort study. Obes Surg 21:1870–1878CrossRefPubMed
31.
Zurück zum Zitat Worni M, Guller U, Shah A, Gandhi M, Shah J, Rajgor D, Pietrobon R, Jacobs DO, Ostbye T (2012) Cholecystectomy concomitant with laparoscopic gastric bypass: a trend analysis of the nationwide inpatient sample from 2001 to 2008. Obes Surg 22:220–229CrossRefPubMed Worni M, Guller U, Shah A, Gandhi M, Shah J, Rajgor D, Pietrobon R, Jacobs DO, Ostbye T (2012) Cholecystectomy concomitant with laparoscopic gastric bypass: a trend analysis of the nationwide inpatient sample from 2001 to 2008. Obes Surg 22:220–229CrossRefPubMed
32.
Zurück zum Zitat Warschkow R, Tarantino I, Ukegjini K, Beutner U, Guller U, Schmied BM, Muller SA, Schultes B, Thurnheer M (2013) Concomitant cholecystectomy during laparoscopic Roux-en-Y gastric bypass in obese patients is not justified: a meta-analysis. Obes Surg 23:397–407CrossRefPubMed Warschkow R, Tarantino I, Ukegjini K, Beutner U, Guller U, Schmied BM, Muller SA, Schultes B, Thurnheer M (2013) Concomitant cholecystectomy during laparoscopic Roux-en-Y gastric bypass in obese patients is not justified: a meta-analysis. Obes Surg 23:397–407CrossRefPubMed
33.
Zurück zum Zitat Ammori BJ, Vezakis A, Davides D, Martin IG, Larvin M, McMahon MJ (2001) Laparoscopic cholecystectomy in morbidly obese patients. Surg Endosc 15:1336–1339CrossRefPubMed Ammori BJ, Vezakis A, Davides D, Martin IG, Larvin M, McMahon MJ (2001) Laparoscopic cholecystectomy in morbidly obese patients. Surg Endosc 15:1336–1339CrossRefPubMed
34.
Zurück zum Zitat Lazzati A, Guy-Lachuer R, Delaunay V, Szwarcensztein K, Azoulay D (2013) Bariatric surgery trends in France: 2005–2011. Surg Obes Relat Dis 10(2):328–334CrossRefPubMed Lazzati A, Guy-Lachuer R, Delaunay V, Szwarcensztein K, Azoulay D (2013) Bariatric surgery trends in France: 2005–2011. Surg Obes Relat Dis 10(2):328–334CrossRefPubMed
Metadaten
Titel
Concomitant cholecystectomy during laparoscopic sleeve gastrectomy
verfasst von
Asnat Raziel
Nasser Sakran
Amir Szold
David Goitein
Publikationsdatum
01.09.2015
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 9/2015
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-014-4010-z

Weitere Artikel der Ausgabe 9/2015

Surgical Endoscopy 9/2015 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.